Sugarloaf Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Sugarloaf Wealth Management's GILD Position: Q4 2024 in Review
Sugarloaf Wealth Management increased its Gilead Sciences (GILD) stake by 7.3% in Q4 2024, buying an estimated $4.32K and bringing the position to 703 shares worth $64.9K. The position accounts for 0.01% of the portfolio, ranked #274.
Sugarloaf Wealth Management first reported a position in GILD in Q4 2019 and has held it in 21 quarters since. The position peaked at $180K in Q2 2020. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.
- Sugarloaf Wealth Management held 703 shares of Gilead Sciences worth $64.9K as of Q4 2024.
- Sugarloaf Wealth Management bought 48 Gilead Sciences shares in Q4 2024, an estimated $4.32K.
- Gilead Sciences made up 0.01% of Sugarloaf Wealth Management's portfolio in Q4 2024, its #274 holding.
- Sugarloaf Wealth Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 21 quarters since.
- Sugarloaf Wealth Management's Gilead Sciences position peaked at $180K in Q2 2020.
- 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.
Based on Sugarloaf Wealth Management's 13F filing for Q4 2024, filed 10 Jan 2025.